A phase I/II trial of radioimmunotherapy with ¹³¹Iodine labelled A5B7 anti-CEA antibody (¹³¹I-A5B7) in combination with Combretastatin-A4-Phosphate (CA4P) in advanced gastrointestinal carcinomas

A. M. Gaya, J. Violet, G. Dancey, A. Green, M. Stratford, S. Sharma, K. Owen,A. Padhani,G. J. Rustin, R. H. Begent,T. Meyer

Journal of Clinical Oncology（2008）

引用 2|浏览0